Home/Filings/4/0001179110-20-009273
4//SEC Filing

Shafer Bradford J 4

Accession 0001179110-20-009273

CIK 0001583107other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 6:34 PM ET

Size

4.5 KB

Accession

0001179110-20-009273

Insider Transaction Report

Form 4
Period: 2020-08-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2020-08-20$18.22/sh4,804$87,529256,723 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001302448

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:34 PM ET
Size
4.5 KB